Post-authorisation active surveillance of the Safety of COVID-19 Vaccine AstraZeneca (AZD-1222) in the UK: A consortium study
- The aim of this study is to monitor the safety and utilisation of the COVID-19 Vaccine AstraZeneca (AZD-1222) administered to vaccines under real-world use in the UK
- Recruitment is ongoing and flyers are being distributed at the Solebay Health Centre and The Beaches Medical Centre vaccination sites.